Capital Fund Management (CFM)’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-28,200
Closed -$469K 1944
2024
Q4
$469K Sell
28,200
-23,000
-45% -$307K ﹤0.01% 1921
2024
Q3
$658K Sell
51,200
-15,100
-23% -$218K ﹤0.01% 1795
2024
Q2
$741K Sell
66,300
-50,300
-43% -$586K ﹤0.01% 1679
2024
Q1
$1.45M Buy
116,600
+24,900
+27% +$415K ﹤0.01% 1585
2023
Q4
$2.43M Buy
91,700
+16,100
+21% +$470K 0.01% 1443
2023
Q3
$3.45M Buy
75,600
+27,400
+57% +$1.27M 0.01% 1130
2023
Q2
$1.99M Buy
+48,200
New +$1.58M 0.01% 1188

Other funds holding AEHR

Capital Fund Management (CFM)'s AEHR Position: Q4 2023 in Review

Capital Fund Management (CFM) sold out of Aehr Test Systems (AEHR) in Q4 2023, closing a stake of 94,725 shares — an estimated $2.76M sold.

Capital Fund Management (CFM) first reported a position in AEHR in Q4 2021 and held it in 4 quarters. The position peaked at $5.42M in Q4 2021. 168 funds tracked by Wall St. Rank hold AEHR as of Q4 2023.

  • Capital Fund Management (CFM) reported no remaining Aehr Test Systems position as of Q4 2023 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 94,725 Aehr Test Systems shares in Q4 2023, an estimated $2.76M.
  • Capital Fund Management (CFM) first reported a position in Aehr Test Systems in Q4 2021 and held it in 4 quarters.
  • Capital Fund Management (CFM)'s Aehr Test Systems position peaked at $5.42M in Q4 2021.
  • 168 funds tracked by Wall St. Rank held Aehr Test Systems as of Q4 2023.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2023, filed 14 Feb 2024.